20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw

Bernhard Zöllner, Jörg Petersen, Matthias Schröter, Rainer Laufs, Volker Schoder, Heinz-Hubert Feucht

Open source

DOI
10.1016/s0140-6736(00)04219-7
Published
2001-03
Container
The Lancet
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-00-04219-7,
  title = {20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw},
  author = {Bernhard Zöllner and Jörg Petersen and Matthias Schröter and Rainer Laufs and Volker Schoder and Heinz-Hubert Feucht},
  year = {2001},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(00)04219-7},
  url = {https://doi.org/10.1016/s0140-6736(00)04219-7}
}

RIS

TY  - JOUR
TI  - 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw
AU  - Bernhard Zöllner
AU  - Jörg Petersen
AU  - Matthias Schröter
AU  - Rainer Laufs
AU  - Volker Schoder
AU  - Heinz-Hubert Feucht
PY  - 2001
JO  - The Lancet
DO  - 10.1016/s0140-6736(00)04219-7
UR  - https://doi.org/10.1016/s0140-6736(00)04219-7
ER  - 

APA

Zöllner, B., Petersen, J., Schröter, M., Laufs, R., Schoder, V., & Feucht, H. (2001). 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. The Lancet. https://doi.org/10.1016/s0140-6736(00)04219-7

Source records